Methazolamide
- Level
- Commodity
- Parent
- 51191500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51191560This classification denotes a diuretic and carbonic anhydrase inhibitor with the molecular formula C5H8N4O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W733B0S9SD, chemically known as 5-acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide but generally known as methazolamide, which bears US NIH Compound Identifier 4100. European Medicines Agency schedules Methazolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08843MIG. The term METHAZOLAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methazolamide in its Anatomical Therapeutic Chemical (ATC) Classification. METHAZOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methazolamide under HS 29350090 and SITC 51580. As of Q4 2014, METHAZOLAMIDE remains the US FDA Preferred Term for this commodity. Methazolamide bears US NLM identifiers UMLS ID C0025631 and NCI Concept Code C61318. SMILES: S(=O)(=O)(N)C1S/C(=N\C(=O)C)N(N1)C.
Same parent
Under 51191500 · 77Activities that produce or sell this
KBLI · 9Inherited from family 51190000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.